● Recruiting

A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma

Condition: Choroidal Melanoma · Indeterminate Lesions · Uveal Melanoma · Sponsor: Aura Biosciences

PhasePhase 3

Planned participants100

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The primary objective is to determine the safety and efficacy of belzupacap sarotalocan (bel-sar) compared to sham control in patients with primary indeterminate lesions (IL) or small choroidal melanoma (CM).

This description comes directly from the study's public registry record.

Talk to the study team

Medical Monitor · 617-500-8864 · clinical@aurabiosciences.com

Always discuss trial participation with your own doctor first.

Locations (71)

Retina Consultants of Alabama	Birmingham, Alabama, United States	Withdrawn
UCSD Shiley Eye Institute, Jacobs Retina Center	La Jolla, California, United States	Recruiting
Doris Stein Eye Research Center	Los Angeles, California, United States	Recruiting
Stanford University School of Medicine	Palo Alto, California, United States	Recruiting
Retinal Consultants Medical Group, Inc.	Sacramento, California, United States	Recruiting
Bascom Palmer Eye Institute	Miami, Florida, United States	Withdrawn
Retina Associates of Florida, PA	Tampa, Florida, United States	Recruiting
Emory Eye Center	Atlanta, Georgia, United States	Recruiting
University of Illinois at Chicago	Chicago, Illinois, United States	Recruiting
Tufts Medical Center New England Eye Center	Boston, Massachusetts, United States	Recruiting
Massachusetts Eye and Ear	Boston, Massachusetts, United States	Recruiting
W.K. Kellogg Eye Center - University of Michigan	Ann Arbor, Michigan, United States	Recruiting

+ 59 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06007690